Sr. Engineer - Lab Automation Software Engineer at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

B.S. in Computer Science, Software Engineering, Bioengineering/Engineering with at least 5 years of relevant industry experience
M.S. in Computer Science, Software Engineering, Bioengineering/Engineering with at least 2 years of relevant industry experience
Strong proficiency in Python, SQL, and JavaScript
Working knowledge of additional programming/scripting languages such as C#, VBA, R, C++, MATLAB, Bash
Strong problem-solving skills and ability to work cross-functionally with scientific and engineering teams

Responsibilities

Develop software applications that orchestrate complex automated laboratory workflows and closed-loop learning systems
Build data pipelines and visualization tools that provide real-time insights into lab operations and experimental outcomes
Implement machine learning models for visual inspection systems, predictive maintenance, and process optimization that enhance operational efficiency
Contribute to digital lab infrastructure including IoT integrations, digital lab twin models, and telemetry monitoring systems
Develop and maintain integrations across multiple automation schedulers, LIMS, and data platforms
Support robust software deployment through best DevOps practices and cloud-based solutions

Skills

Lab Automation

Software Engineering

Data Pipelines

Robotic Platforms

Closed-Loop Systems

Laboratory Workflows

Visualization Tools

Artificial Intelligence

Digitalization

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free